Valeska Schroeder

Stories

Medicare adds PearlMatrix bone graft to new-technology payment program

Leading Cerapedics through FDA approval, label expansion, and NTAP designation

Hospitals that use PearlMatrix, a peptide-enhanced bone graft proven to speed lumbar fusion, can now claim up to 65% of its added cost back from Medicare. The Centers for Medicare & Medicaid Services (CMS) granted the graft New Technology Add-on Payment (NTAP) status, effective October 1, 2026.

Updated Yesterday

Notable Quotes

With the NTAP approval, financial barriers for hospitals may be lowered, allowing more patients access to PearlMatrix.

from Medicare adds PearlMatrix bone graft to new-technology payment program · Updated Yesterday

Our P-15 drug-device products are supported by extensive human clinical evidence, including the long-standing proven safety and efficacy of i-FACTOR in the cervical spine.

from Medicare adds PearlMatrix bone graft to new-technology payment program · Updated Yesterday